GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Magnasense AB (FRA:52Q) » Definitions » Market Cap

Magnasense AB (FRA:52Q) Market Cap : €1.87 Mil (As of Apr. 02, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Magnasense AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Magnasense AB's share price for the quarter that ended in Dec. 2024 was €0.0077. Magnasense AB's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 62.34 Mil. Therefore, Magnasense AB's market cap for the quarter that ended in Dec. 2024 was €0.48 Mil.

Magnasense AB's quarterly market cap declined from Jun. 2024 (€1.41 Mil) to Sep. 2024 (€1.14 Mil) and declined from Sep. 2024 (€1.14 Mil) to Dec. 2024 (€0.48 Mil).

Magnasense AB's annual market cap declined from Dec. 2022 (€3.85 Mil) to Dec. 2023 (€2.90 Mil) and declined from Dec. 2023 (€2.90 Mil) to Dec. 2024 (€0.48 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Magnasense AB's Enterprise Value for Today is €5.89 Mil.


Magnasense AB Market Cap Historical Data

The historical data trend for Magnasense AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magnasense AB Market Cap Chart

Magnasense AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial 25.32 96.87 3.85 2.90 0.48

Magnasense AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.90 1.77 1.41 1.14 0.48

Competitive Comparison of Magnasense AB's Market Cap

For the Medical Devices subindustry, Magnasense AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magnasense AB's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Magnasense AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Magnasense AB's Market Cap falls into.


;
;

Magnasense AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Magnasense AB's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=€0.0077*62.339
=€0.48

Magnasense AB's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=€0.0077*62.339
=€0.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magnasense AB  (FRA:52Q) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Magnasense AB Market Cap Related Terms

Thank you for viewing the detailed overview of Magnasense AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Magnasense AB Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.

Magnasense AB Headlines

No Headlines